Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Growth 2021-2026
According to this latest study, the 2020 growth of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors will have significant change from previous year. By the most conservative estimates of global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 8843.8 million in 2019. Over the next five years the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market will register a 2.4% CAGR in terms of revenue, the global market size will reach US$ 9705.9 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Nesina
Tradjenta
Onglyza
Januvia
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Type 2 Diabetes
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Sanofi
Takeda
Eli Lilly
Merck
Novo Nordisk
Bristol-Myers Squibb
Pfizer
AstraZeneca
GlaxoSmithKline
Boehringer Ingelheim
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption 2016-2026
2.1.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption CAGR by Region
2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Type
2.2.1 Nesina
2.2.2 Tradjenta
2.2.3 Onglyza
2.2.4 Januvia
2.2.5 Others
2.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type
2.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2016-2021)
2.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Type (2016-2021)
2.3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Type (2016-2021)
2.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Application
2.4.1 Type 2 Diabetes
2.4.2 Others
2.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application
2.5.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Market Share by Application (2016-2021)
2.5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Application (2016-2021)
2.5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Application (2016-2021)
3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Company
3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Company
3.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Company (2019-2021)
3.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Company (2019-2021)
3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Company
3.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Company (2019-2021)
3.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Company (2019-2021)
3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Company
3.4 Global Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Location Distribution
3.4.2 Players Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Region
4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Region
4.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region
4.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region
4.2 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth
4.3 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth
4.4 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth
4.5 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth
5 Americas
5.1 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country
5.1.1 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2016-2021)
5.1.2 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2016-2021)
5.2 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type
5.3 Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region
6.1.1 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2016-2021)
6.1.2 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2016-2021)
6.2 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type
6.3 APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Country
7.1.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2016-2021)
7.1.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2016-2021)
7.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type
7.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Country
8.1.1 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2016-2021)
8.1.2 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2016-2021)
8.2 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type
8.3 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors
10.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customer
11 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast
11.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast by Region
11.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast by Regions (2021-2026)
11.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast by Type
11.7 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast by Application
12 Key Players Analysis
12.1 Sanofi
12.1.1 Sanofi Sanofi Company Information
12.1.2 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
12.1.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Sanofi Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 Takeda
12.2.1 Takeda Company Information
12.2.2 Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
12.2.3 Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Takeda Main Business Overview
12.2.5 Takeda Latest Developments
12.3 Eli Lilly
12.3.1 Eli Lilly Company Information
12.3.2 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
12.3.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Eli Lilly Main Business Overview
12.3.5 Eli Lilly Latest Developments
12.4 Merck
12.4.1 Merck Company Information
12.4.2 Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
12.4.3 Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Merck Main Business Overview
12.4.5 Merck Latest Developments
12.5 Novo Nordisk
12.5.1 Novo Nordisk Company Information
12.5.2 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
12.5.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Novo Nordisk Main Business Overview
12.5.5 Novo Nordisk Latest Developments
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Company Information
12.6.2 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
12.6.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Bristol-Myers Squibb Main Business Overview
12.6.5 Bristol-Myers Squibb Latest Developments
12.7 Pfizer
12.7.1 Pfizer Company Information
12.7.2 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
12.7.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Pfizer Main Business Overview
12.7.5 Pfizer Latest Developments
12.8 AstraZeneca
12.8.1 AstraZeneca Company Information
12.8.2 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
12.8.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 AstraZeneca Main Business Overview
12.8.5 AstraZeneca Latest Developments
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Company Information
12.9.2 GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
12.9.3 GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 GlaxoSmithKline Main Business Overview
12.9.5 GlaxoSmithKline Latest Developments
12.10 Boehringer Ingelheim
12.10.1 Boehringer Ingelheim Company Information
12.10.2 Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
12.10.3 Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Boehringer Ingelheim Main Business Overview
12.10.5 Boehringer Ingelheim Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Nesina
Table 3. Major Players of Tradjenta
Table 4. Major Players of Onglyza
Table 5. Major Players of Januvia
Table 6. Major Players of Others
Table 7. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2016-2021) & (K MT)
Table 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2016-2021)
Table 9. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2016-2021) & ($ million)
Table 10. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2016-2021)
Table 11. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Type (2016-2021)
Table 12. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2016-2021) & (K MT)
Table 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2016-2021)
Table 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Value by Application (2016-2021)
Table 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2016-2021)
Table 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Application (2016-2021)
Table 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Company (2019-2021) & (K MT)
Table 18. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Company (2019-2021)
Table 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Company (2019-2021)
Table 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Producing Area Distribution and Sales Area
Table 23. Players Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
Table 24. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2016-2021) (K MT)
Table 28. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2016-2021)
Table 29. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2016-2021)
Table 31. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 32. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 33. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 35. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2016-2021) & (K MT)
Table 36. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2016-2021)
Table 37. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2016-2021) & (K MT)
Table 38. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2016-2021)
Table 39. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2016-2021) & (K MT)
Table 40. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2016-2021)
Table 41. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2016-2021)
Table 43. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2016-2021) & (K MT)
Table 44. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2016-2021)
Table 45. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2016-2021) & (K MT)
Table 46. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2016-2021)
Table 47. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 48. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 49. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 51. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2016-2021) & (K MT)
Table 52. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2016-2021)
Table 53. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2016-2021) & (K MT)
Table 54. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 56. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2016-2021) & (K MT)
Table 60. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2016-2021) & (K MT)
Table 62. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2016-2021)
Table 63. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Type (2021-2026) & (K MT)
Table 64. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share Forecast by Type (2021-2026)
Table 65. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 66. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share Forecast by Type (2021-2026)
Table 67. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Application (2021-2026) & (K MT)
Table 68. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share Forecast by Application (2021-2026)
Table 69. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 70. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share Forecast by Application (2021-2026)
Table 71. Sanofi Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 72. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
Table 73. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 74. Sanofi Main Business
Table 75. Sanofi Latest Developments
Table 76. Takeda Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 77. Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
Table 78. Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 79. Takeda Main Business
Table 80. Takeda Latest Developments
Table 81. Eli Lilly Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 82. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
Table 83. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 84. Eli Lilly Main Business
Table 85. Eli Lilly Latest Developments
Table 86. Merck Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 87. Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
Table 88. Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 89. Merck Main Business
Table 90. Merck Latest Developments
Table 91. Novo Nordisk Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 92. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
Table 93. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 94. Novo Nordisk Main Business
Table 95. Novo Nordisk Latest Developments
Table 96. Bristol-Myers Squibb Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 97. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
Table 98. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 99. Bristol-Myers Squibb Main Business
Table 100. Bristol-Myers Squibb Latest Developments
Table 101. Pfizer Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 102. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
Table 103. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 104. Pfizer Main Business
Table 105. Pfizer Latest Developments
Table 106. AstraZeneca Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 107. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
Table 108. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 109. AstraZeneca Main Business
Table 110. AstraZeneca Latest Developments
Table 111. GlaxoSmithKline Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 112. GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
Table 113. GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 114. GlaxoSmithKline Main Business
Table 115. GlaxoSmithKline Latest Developments
Table 116. Boehringer Ingelheim Basic Information, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 117. Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
Table 118. Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 119. Boehringer Ingelheim Main Business
Table 120. Boehringer Ingelheim Latest Developments
List of Figures
Figure 1. Picture of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 2. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Nesina
Figure 10. Product Picture of Tradjenta
Figure 11. Product Picture of Onglyza
Figure 12. Product Picture of Januvia
Figure 13. Product Picture of Others
Figure 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type in 2020
Figure 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2016-2021)
Figure 16. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumed in Type 2 Diabetes
Figure 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market: Type 2 Diabetes (2016-2021) & (K MT)
Figure 18. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumed in Others
Figure 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market: Others (2016-2021) & (K MT)
Figure 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2016-2021)
Figure 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application in 2020
Figure 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Company in 2020
Figure 24. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Regions (2016-2021)
Figure 25. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region in 2020
Figure 26. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2016-2021 (K MT)
Figure 27. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2016-2021 ($ Millions)
Figure 28. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2016-2021 (K MT)
Figure 29. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2016-2021 ($ Millions)
Figure 30. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2016-2021 (K MT)
Figure 31. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2016-2021 (K MT)
Figure 33. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2016-2021 ($ Millions)
Figure 34. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country in 2020
Figure 35. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country in 2020
Figure 36. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type in 2020
Figure 37. Americas Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application in 2020
Figure 38. United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region in 2020
Figure 43. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Regions in 2020
Figure 44. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type in 2020
Figure 45. APAC Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application in 2020
Figure 46. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country in 2020
Figure 53. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country in 2020
Figure 54. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type in 2020
Figure 55. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application in 2020
Figure 56. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application in 2020
Figure 65. Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets